# Yale New Haven Health account plan

> Yale New Haven Health is a not-for-profit Connecticut health system of five hospitals with FY2025 operating revenue of $7,579.6 million.

## At a glance

Yale New Haven Health System is a not-for-profit integrated regional healthcare delivery system formed in 1983, coordinating Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital, Lawrence + Memorial and Westerly hospitals, the Northeast Medical Group physician organization, home care and urgent care in Connecticut, New York, Rhode Island and Massachusetts. In the fiscal year ended September 30, 2025 total operating revenue was $7,579.6 million, including $6,423.1 million of patient service revenue and $988.3 million of pharmacy sales. It posted an operating loss of $196.8 million after restructuring, but an excess of revenue over expenses of $91.3 million thanks to nonoperating gains; net assets were $4,813.0 million. The statements give no headcount.

## Business units

- **Yale New Haven Hospital**: The System's flagship and issuer of most of its bonds, parent of long-term care, ambulatory surgery and Medical Center Pharmacy and Home Care subsidiaries. It is building the neuroscience tower, with about $172.1 million of commitments remaining at September 30, 2025.
- **Bridgeport Hospital**: Hospital with its foundation and a real estate holding company; along with Yale New Haven it functions as a safety-net institution.
- **Greenwich Hospital**: Serves lower Fairfield County, Connecticut and Westchester County, New York, supported by the Greenwich Hospital Endowment Fund. Its COO and CFO roles were eliminated in the 2025 restructuring.
- **Lawrence + Memorial Corporation**: Lawrence + Memorial Hospital in Connecticut and Westerly Hospital in Rhode Island, with related service entities.
- **Northeast Medical Group**: Tax-exempt medical organization providing physician services to the System's hospitals and their communities.
- **Yale New Haven Health at Home**: Home care network, renamed in April 2025, which took over the Visiting Nurse Association of Southeastern Connecticut from October 1, 2024.
- **Yale New Haven Health Urgent Care**: Former PhysicianOne Urgent Care, fully acquired in October 2023, providing urgent care in Connecticut, New York and Massachusetts.
- **Corporate Professional Business Services**: For-profit subsidiary that manages physician practices and provides third-party administration on certain managed care contracts.

## Strategic priorities

- **Return to operating surplus**: Management expects to return to positive operating results in fiscal 2026 with a projected $50 million surplus, after an operating loss of $196.8 million in FY2025.
- **Operating model redesign**: A March 2025 redesign restructured inpatient and ambulatory operations and consolidated management and administrative roles to speed decisions.
- **Workforce cost reduction**: A voluntary retirement program drew 600 acceptances; the System expects to hire about 400 replacements and save about $50 million.
- **Ambulatory and urgent care expansion**: The board has provided seed money to expand urgent and ambulatory care into central Connecticut.
- **Complete major projects**: The 505,000-square-foot Neurosciences Center in New Haven and the $75 million Connecticut Proton Therapy Center in Wallingford are expected to complete in 2026.

## Investments and deals

- **Capital program**: Property, plant and equipment acquisitions were $464.1 million in FY2025, and construction in progress rose to $659.8 million; remaining commitments were about $172.1 million for the neuroscience tower and $183.4 million for other projects.
- **Connecticut Proton Therapy Center**: A $75 million, 25,000-square-foot center in Wallingford developed jointly with Hartford HealthCare.
- **Exit from the Prospect hospitals deal**: The System paid Prospect Medical Holdings $45.0 million in October 2025 to terminate its agreement to acquire three Connecticut hospitals.
- **Restructuring**: FY2025 included $57.7 million of severance payments and vendor-contract termination costs.

## Challenges and risks

- **Operating losses**: Operating income before depreciation, interest and restructuring fell to $160.3 million from $286.3 million, and the System has had deficits in three of the last four fiscal years.
- **Rising costs and low reimbursement**: Drug and equipment costs keep rising while Medicare and Medicaid reimbursement remains low and federal research funding and ACA subsidies shrink.
- **Safety-net burden**: Uncompensated care cost approximately $98.1 million in FY2025, and the System paid $316.8 million into the Connecticut DSH assessment.
- **Cybersecurity**: A March 2025 data breach affected about 5.6 million patients and led to an $18 million settlement.
- **Rating pressure**: S&P kept its AA- rating with a negative outlook, citing operating losses and large construction projects including an $838 million neuroscience tower.

## What leadership says

> "The headwinds are strong" — Christopher O'Connor, CEO (until June 2026), Interview with the Hartford Business Journal, December 1, 2025

> "I'm confident in the steps that we've taken that we will hit our budget this year and continue that stabilization journey" — Christopher O'Connor, CEO (until June 2026), Interview with the Hartford Business Journal, December 1, 2025

> "The board has already given us the seed money necessary to initiate that work. So we are absolutely going to continue our ambulatory expansion." — Christopher O'Connor, CEO (until June 2026), Interview with the Hartford Business Journal, December 1, 2025


## Where a supplier can help

- **Cost and supply savings**: With supplies and other costs at $3,638.1 million and a target to return to surplus in fiscal 2026, procurement, pharmacy and cost-reduction offerings fit.
- **Ambulatory and urgent care rollout**: The central Connecticut ambulatory expansion needs site development, equipment, scheduling and patient-access technology.
- **Cybersecurity after the breach**: The data breach affecting about 5.6 million patients makes security, identity and data protection a clear need.
- **Workforce transition**: Hiring about 400 replacements after the voluntary retirement program suits recruiting, onboarding and knowledge-transfer services.
- **Construction and facility fit-out**: The Neurosciences Center and proton therapy projects completing in 2026 open room for medical equipment, fit-out and facility services.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Yale New Haven Health Services Corporation (d/b/a Yale New Haven Health System) - Audited Consolidated Financial Statements and Single Audit Reports, Year ended September 30, 2025](https://app.fac.gov/dissemination/report/pdf/2025-09-GSAFAC-0000421846)

Annual report · 2025-12-16

- Yale New Haven Health Services Corporation (d/b/a Yale New Haven Health System, YNHHS) is a not-for-profit integrated regional healthcare delivery system, formed in 1983, parent of Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital, Lawrence + Memorial Corporation (L+M and Westerly Hospital), Northeast Medical Group, YNH Health at Home and Yale New Haven Health Urgent Care.
- FY2025 (year ended September 30, 2025) total operating revenue was $7,579.6 million, up from $7,237.3 million; patient service revenue $6,423.1 million and other revenue $1,156.5 million (of which pharmacy sales $988.3 million).
- The System swung to an operating loss of $196.8 million (vs. operating income of $46.2 million in FY2024), including $57.7 million of restructuring expenses (severance and termination of certain vendor contracts); excess of revenue over expenses fell to $91.3 million from $410.8 million, carried by $288.2 million of nonoperating gains.
- Cost pressure: salaries and benefits rose to $3,654.3 million and supplies and other to $3,638.1 million; depreciation and amortization rose to $265.3 million, including $26.7 million of goodwill amortization after adopting the private company alternative.
- Payer mix of patient service revenue: nongovernmental $3,157.8 million, Medicare $2,381.9 million, Medicaid $883.4 million; inpatient $2,935.9 million vs. outpatient $3,487.2 million.
- Balance sheet: total assets $9,264.1 million, net assets $4,813.0 million, cash and short-term investments $606.6 million and $3,117.0 million; long-term debt $1,675.4 million net of current portion; revolving lines of credit raised to $300 million (undrawn).
- Capex: $464.1 million of property, plant and equipment acquired in FY2025; construction in progress $659.8 million; contractual commitments of about $172.1 million for the neuroscience tower and $183.4 million for all other projects.
- The System settled its dispute with Prospect Medical Holdings over the terminated purchase of three Connecticut hospitals by agreeing to pay $45.0 million (paid October 2025); government agencies have requested information relating to patient billings.
- KPMG issued an unmodified opinion dated December 16, 2025; no audit findings, and the System qualified as a low-risk auditee under the Uniform Guidance.

### [Yale New Haven Health CEO O'Connor details tough year, restructuring and plans for recovery (Hartford Business Journal, reprinted by the Connecticut Hospital Association)](https://cthosp.org/daily-news-clip/yale-new-haven-health-ceo-oconnor-details-tough-year-restructuring-and-plans-for-recovery/)

Executive talk · Christopher O'Connor, Chief Executive Officer (until June 2026) · 2025-12-01

- Hartford Business Journal interview (December 1, 2025) with Christopher O'Connor, then CEO of Yale New Haven Health System; he left the System in June 2026.
- O'Connor called the year full of "constant challenges and curveballs": rising drug and equipment costs, shrinking federal research funding, reduced ACA subsidies and low Medicare and Medicaid rates. "The headwinds are strong," he said.
- He said the System had a $40 million net operating loss through the third quarter of fiscal 2025 but projected a return to positive operating results in fiscal 2026, with a $50 million surplus.
- He attributed the fiscal 2024 surplus of $46.2 million largely to a one-time $100 million 340B settlement.
- A voluntary retirement program drew 600 employees; about 400 will be rehired, cutting roughly 200 positions and saving about $50 million.
- He initiated the departures of CFO Gail W. Kosyla and General Counsel Bill Aseltyne; Greenwich Hospital's COO and CFO roles were eliminated.
- The Prospect settlement ($45 million) and data breach settlement ($18 million) total $63 million; he called the breach settlement "victim shaming".
- Growth: ambulatory and urgent care expansion into central Connecticut ("we are absolutely going to continue our ambulatory expansion"), the 505,000-square-foot Neurosciences Center and the $75 million Connecticut Proton Therapy Center due in 2026.

## Questions about Yale New Haven Health

### What is Yale New Haven Health?

A not-for-profit integrated healthcare system in Connecticut that coordinates five hospitals, a physician group, home care and urgent care.

### What is Yale New Haven Health's revenue?

Total operating revenue was $7,579.6 million in the fiscal year ended September 30, 2025, up from $7,237.3 million.

### Is Yale New Haven Health profitable?

It had an operating loss of $196.8 million in FY2025 but an excess of revenue over expenses of $91.3 million after nonoperating gains; management projected a $50 million operating surplus for fiscal 2026.

### What is Yale New Haven Health's strategy?

Stabilize finances through an operating model redesign and workforce savings, expand ambulatory and urgent care into central Connecticut, and complete the Neurosciences Center and proton therapy center.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
